Annovis Bio, Inc. (FRA:07X)
Germany · Delayed Price · Currency is EUR 2.920
-0.010 (-0.34%)
At close: Jan 2, 2026
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of €83.62 million as of January 9, 2026. Its market cap has increased by 41.28% in one year.
Market Cap
83.62M
Enterprise Value
70.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.92
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from 56.82M to 83.62M, an increase of 47.16%. That is a compound annual growth rate of 6.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 83.62M | 7.07% |
| Dec 31, 2025 | 78.10M | 16.51% |
| Dec 31, 2024 | 67.03M | -61.39% |
| Dec 29, 2023 | 173.62M | 69.23% |
| Dec 30, 2022 | 102.59M | -18.07% |
| Dec 31, 2021 | 125.22M | 194.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |